Indicators of salivary gland inflammation in primary Sjögren's syndrome

European Journal of Oral Sciences

Volumn 105, Issue 3, 1997, Pages 228-233

  Cuida, Mihaela ^a   Halse, Anne Kristine ^a   Johannessen, Anne Christine ^a   Tynning, Turid ^a   Jonsson, Roland ^a  

^a UNIVERSITY OF BERGEN   (Norway)

Author keywords

Calprotectin; sICAM 1; sIL 2R ; Sj gren's syndrome; sVCAM 1

Indexed keywords

ALBUMINOID; AUTACOID; CALCIUM BINDING PROTEIN; CALGRANULIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 2 RECEPTOR; MEMBRANE ANTIGEN; NERVE CELL ADHESION MOLECULE; SECRETORY IMMUNOGLOBULIN; SERUM ALBUMIN; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; AGED; ARTICLE; BLOOD; CHEMISTRY; COMPARATIVE STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; METABOLISM; MIDDLE AGED; PAROTID GLAND; PATHOLOGY; SALIVA; SECRETION; SIALOADENITIS; SJOEGREN SYNDROME;

ADULT; AGED; ALBUMINS; ANTIGENS, SURFACE; CALCIUM-BINDING PROTEINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN A, SECRETORY; IMMUNOGLOBULIN G; INFLAMMATION MEDIATORS; INTERCELLULAR ADHESION MOLECULE-1; LEUKOCYTE L1 ANTIGEN COMPLEX; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; PAROTID GLAND; RECEPTORS, INTERLEUKIN-2; SALIVA; SERUM ALBUMIN; SIALADENITIS; SJOGREN'S SYNDROME; VASCULAR CELL ADHESION MOLECULE-1;

EID: 0031158893     PISSN: 09098836     EISSN: 16000722     Source Type: Journal    
DOI: 10.1111/j.1600-0722.1997.tb00205.x     Document Type: Article

References (35)

1. MOUTSOPOULOS HM, CHUSED TM, DE MANN L, KLIPPEL JH, FAUCI AS, FRANK MM, LAWLEY TJ, HAMBURGER MI. Sjögren's syndrome (sicca syndrome): Current Issues. Ann Intern Med 1980; 92: 212-226.
2. JONSSON R, MOUNTZ J, KOOPMAN W. Elucidating the pathogenesis of autoimmune disease: recent advances at the molecular level and relevance to oral mucosal disease. J Oral Pathol Med 1990; 19: 341-350.
3. VITALI C, BOMBARDIERI S, MOUTSOPOULOS HM et al. Preliminary criteria for the classification of Sjögren's syndrome: results of a prospective concerted action supported by the European Community. Arthritis Rheum 1993; 36: 340-347.
4. ADAMSON III TC, FOX RI, FRISMAN DM, HOWELL FV. Immunohistologic analysis of lymphoid infiltrates in primary Sjögren's syndrome using monoclonal antibodies. J Immunol 1983; 130: 203-208.
5. OPPENHEIMER-MARKS N, DAVIS LS, BOGUE DT, RAMBERG J, LIPSKY PE. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 1991; 147: 2913-2921.
6. WALDMANN TA. The IL-2/IL-2 receptor system: a target for rational immune intervention. Immunol Today 1993; 14: 264-270.
7. AOKI S, IMAI K, YACHI A. Soluble intercellular adhesion molecule-1 (ICAM-1) antigen in patients with rheumatoid arthritis. Scand J Immunol 1993; 38: 485-490.
8. WELLICOME SM, KAPAHI P, MASON JC, LEBRANCHU Y, YARWOOD H, HASKARD DO. Detection of a circulating form of vascular cell adhesion molecule-1: raised levels in rheumatoid arthritis and systemic lupus erythematosus. Clin Exp Immunol 1993; 92: 412-418.
9. DIAMANT M, TVEDE N, PRAUSE JU, OXHOLM P. Soluble interleukin-2 receptors in serum from patients with primary Sjögren's syndrome. Scand J Rheumatol 1991; 20: 370-372.
10. OXHOLM P. Primary Sjögren's syndrome-Clinical and laboratory markers of disease activity. Semin Arthritis Rheum 1992; 22: 114-126.
11. STUCHELL RN, MANDEL ID, BAURMASH H. Clinical utilization of sialochemistry in Sjögren's syndrome. J Oral Pathol 1984; 13: 303-309.
12. FAGERHOL MK, ANDERSSON KB, NAESS-ANDRESEN C-F, BRANDTZAEG P, DALE I. Calprotectin (The L1 leukocyte protein). In: Smith VL, Dedman JR (eds): Stimulus response coupling. The role of intracellular calcium-binding proteins. Boca Raton: CRC Press, 1990; 187-210.
13. BERNTZEN HB, ENDRESEN GKM, FAGERHOL MK, SPIECHOWICZ J, MOWINCKEL P. Calprotectin (the L1 protein) during surgery in patients with rheumatoid arthritis. Scand J Clin Lab Invest 1991; 51: 643-650.
14. BRUN JG, JONSSON R, HAGA H-J. Measurement of plasma calprotectin as an indicator of arthritis and disease activity in patients with inflammatory rheumatic diseases. J Rheumatol 1994; 21: 733-738.
15. SANDER J, FAGERHOL MK, BAKKEN JS, DALE I. Plasma levels of the leucocyte L1 protein in febrile conditions: relation to aetiology, number of leucocytes in blood, blood sedimentation reaction and C-reactive protein. Scand J Clin Lab Invest 1984; 44: 357-362.
16. SEMB AG, GABRIELSEN T-O, HALSTENSEN TS, FAGERHOL MK, BRANDTZAEG P, VAAGE J. Cardiac surgery and distribution of the leukocyte L1 protein calprotectin. Eur J Cardio-thorac Surg 1991; 5: 363-367.
17. BRUN JG, CUIDA M, JACOBSEN H, KLOSTER R, JOHANNESSEN AC, HOYERAAL HM, JONSSON R. Sjögren's syndrome in inflammatory rheumatic diseases: Analysis of the leukocyte protein calprotectin in plasma and saliva. Scand J Rheumatol 1994; 23: 114-118.
18. DANIELS TE, SILVERMANN S JR, MICHALSKI JP, GREENSPAN JS, SYLVESTER RA, TALAL N. The oral component of Sjögren's syndrome. Oral Surg 1975; 39: 875-885.
19. DANIELS TE. Labial salivary gland biopsy in Sjögren's syndrome: Assessment as a diagnostic criterion in 362 suspected cases. Arthritis Rheum 1984; 27: 147-156.
20. SCHAEFFER ME, RHODES M, PRINCE S, MICHALEK SM, MCGHEE JR. A plastic intraoral device for the collection of human parotid saliva. J Dent Res 1977; 56: 728-733.
21. ROSETH AG, FAGERHOL MK, AADLAND E, SCHJONSBY H. Assessment of the neutrophil dominating protein calprotectin in feces: A methodologic study. Scand J Gastroenterol 1992; 27: 793-798.
22. Fox RI, HUGLI TE, LAMER LL, MORGAN EL, HOWELL F. Salivary gland lymphocytes in primary Sjögren's syndrome lack lymphocyte subsets defined by Leu-7 and Leu-11 antigens. J Immunol 1985; 135: 207-214.
23. AZIZ KE, MCCLUSKEY PJ, MONTANARO A, WAKEFIELD D. Vascular endothelium and lymphocyte adhesion molecules in minor salivary glands of patients with Sjögren's syndrome. J Clin Lab Immunol 1992; 37: 39-49.
24. MASON JC, KAPAHI P, HASKARD DO. Detection of increased levels of circulating intercellular adhesion molecule 1 in some patients with rheumatoid arthritis but not in patients with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 519-527.
25. ROTHLEIN R, MAINOLFI EA, CZAJKOWSKI M, MARLIN SD. A form of circulating ICAM-1 in human serum. J Immunol 1991; 147: 3788-3793.
26. MANOUSSAKIS MN, PAPADOPOULOS GK, DROSOS AA, MOUTSOPOULOS HM. Soluble interleukin 2 receptor molecules in the serum of patients with autoimmune diseases. Clin Immunol Immunopathol 1989; 50: 321-332.
27. 2-microglobulin, and the interleukin 2 receptor in Sjögren's syndrome. Clin Immunol Immunopathol 1987; 45: 235-243.
28. ROWE D, GRIFFITHS M, STEWART J, NOVICK D, BEVERLEY PCL, ISENBERG DA. HLA class I and II, interferon, interleukin 2, and the interleukin 2 receptor expression on labial biopsy specimens from patients with Sjögren's syndrome. Ann Rheum Dis 1987; 46: 580-586.
29. MARKUSSE HM, OTTEN HG, VROOM TM, SMEETS TJ, FOKKENS N, BREEDVELD FC. Rheumatoid factor isotypes in serum and salivary fluid of patients with primary Sjögren's syndrome. Clin Immunol Immunopathol 1993; 66: 26-32.
30. THORN JJ, PRAUSE JU, OXHOLM P. Sialochemistry in Sjögren's syndrome: A review. J Oral Pathol Med 1989; 18: 457-468.
31. BRUN JG, ULVESTAD E, FAGERHOL MK, JONSSON R. Effects of human calprotectin (L1) on in vitro immunoglobulin synthesis. Scand J Immunol 1994; 40: 675-680.
32. OPPENHEIM FG. Preliminary observations on the presence and origin of serum albumin in human saliva. Helv Odont Acta 1970; 14: 10-17.
33. MANDEL ID, BAURMASH H. Sialochemistry in Sjögren's syndrome. Oral Surg 1976; 41: 182-187.
34. CUIDA M, BRUN JG, JOHANNESSEN AC, JONSSON R. Immunohistochemical characterization of the cellular infiltrates in Sjögren's syndrome, rheumatoid arthritis and osteoarthritis with special reference to calprotectin producing cells. APMIS 1996; 104: 881-890.
35. EVERSOLE LR, MIYASAKI KT, CHRISTENSEN RE. Keratinocyte expression of calprotectin in oral inflammatory mucosal diseases. J Oral Pathol Med 1993; 22: 303-307.